Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(methotrexate). Showing records 1 – 30 of 127 total matches.

[1] [2] [3] [4] [5]

Search Limiters

Last 2 Years | English Only

Levels

Languages

Country

▼ Search Limiters


University of Manchester

1. Owen, Sally-Anne. Genetic predictors of response to methotrexate in patients with rheumatoid arthritis.

Degree: 2012, University of Manchester

 Abstract The University of Manchester, Sally-Anne Owen, PhD, Genetic predictors of response to methotrexate in patients with rheumatoid arthritis, 2012.Background: Methotrexate (MTX) is the cornerstone… (more)

Subjects/Keywords: Methotrexate; Genetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Owen, S. (2012). Genetic predictors of response to methotrexate in patients with rheumatoid arthritis. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:163482

Chicago Manual of Style (16th Edition):

Owen, Sally-Anne. “Genetic predictors of response to methotrexate in patients with rheumatoid arthritis.” 2012. Doctoral Dissertation, University of Manchester. Accessed April 19, 2019. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:163482.

MLA Handbook (7th Edition):

Owen, Sally-Anne. “Genetic predictors of response to methotrexate in patients with rheumatoid arthritis.” 2012. Web. 19 Apr 2019.

Vancouver:

Owen S. Genetic predictors of response to methotrexate in patients with rheumatoid arthritis. [Internet] [Doctoral dissertation]. University of Manchester; 2012. [cited 2019 Apr 19]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:163482.

Council of Science Editors:

Owen S. Genetic predictors of response to methotrexate in patients with rheumatoid arthritis. [Doctoral Dissertation]. University of Manchester; 2012. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:163482

2. O'FARRELL, LAURA. The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs.

Degree: School of Biochemistry & Immunology. Discipline of Biochemistry, 2017, Trinity College Dublin

 Low-dose Methotrexate (MTX) is a powerful anti-arthritic drug used in the treatment of a variety of inflammatory diseases. It is an economical drug and is… (more)

Subjects/Keywords: PBMC; Methotrexate; Metabolism

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

O'FARRELL, L. (2017). The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs. (Thesis). Trinity College Dublin. Retrieved from http://hdl.handle.net/2262/82002

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

O'FARRELL, LAURA. “The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs.” 2017. Thesis, Trinity College Dublin. Accessed April 19, 2019. http://hdl.handle.net/2262/82002.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

O'FARRELL, LAURA. “The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs.” 2017. Web. 19 Apr 2019.

Vancouver:

O'FARRELL L. The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs. [Internet] [Thesis]. Trinity College Dublin; 2017. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/2262/82002.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

O'FARRELL L. The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs. [Thesis]. Trinity College Dublin; 2017. Available from: http://hdl.handle.net/2262/82002

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pretoria

3. Visser, Suzaan. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85.

Degree: Pharmacology, 2008, University of Pretoria

Methotrexate (MTX) has been used for many years in the treatment of patients with cancer as a cytotoxic agent and as an anti-inflammatory drug for… (more)

Subjects/Keywords: Cytotoxic; Methotrexate; Cancer; UCTD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Visser, S. (2008). The toxicity and therapeutic index of a methotrexate polymeric compound, D-85. (Doctoral Dissertation). University of Pretoria. Retrieved from http://hdl.handle.net/2263/24575

Chicago Manual of Style (16th Edition):

Visser, Suzaan. “The toxicity and therapeutic index of a methotrexate polymeric compound, D-85.” 2008. Doctoral Dissertation, University of Pretoria. Accessed April 19, 2019. http://hdl.handle.net/2263/24575.

MLA Handbook (7th Edition):

Visser, Suzaan. “The toxicity and therapeutic index of a methotrexate polymeric compound, D-85.” 2008. Web. 19 Apr 2019.

Vancouver:

Visser S. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85. [Internet] [Doctoral dissertation]. University of Pretoria; 2008. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/2263/24575.

Council of Science Editors:

Visser S. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85. [Doctoral Dissertation]. University of Pretoria; 2008. Available from: http://hdl.handle.net/2263/24575


University of Pretoria

4. [No author]. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 .

Degree: 2008, University of Pretoria

Methotrexate (MTX) has been used for many years in the treatment of patients with cancer as a cytotoxic agent and as an anti-inflammatory drug for… (more)

Subjects/Keywords: Cytotoxic; Methotrexate; Cancer; UCTD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

author], [. (2008). The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 . (Doctoral Dissertation). University of Pretoria. Retrieved from http://upetd.up.ac.za/thesis/available/etd-05122008-133405/

Chicago Manual of Style (16th Edition):

author], [No. “The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 .” 2008. Doctoral Dissertation, University of Pretoria. Accessed April 19, 2019. http://upetd.up.ac.za/thesis/available/etd-05122008-133405/.

MLA Handbook (7th Edition):

author], [No. “The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 .” 2008. Web. 19 Apr 2019.

Vancouver:

author] [. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 . [Internet] [Doctoral dissertation]. University of Pretoria; 2008. [cited 2019 Apr 19]. Available from: http://upetd.up.ac.za/thesis/available/etd-05122008-133405/.

Council of Science Editors:

author] [. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 . [Doctoral Dissertation]. University of Pretoria; 2008. Available from: http://upetd.up.ac.za/thesis/available/etd-05122008-133405/


University of Manchester

5. Bluett, James A. Developing and investigating response markers to methotrexate in rheumatoid arthritis.

Degree: PhD, 2016, University of Manchester

 Introduction: Rheumatoid arthritis (RA) is a multisystem disease associated with early mortality. Methotrexate (MTX) is the first-line therapy in RA but is associated with significant… (more)

Subjects/Keywords: Rheumatoid arthritis; Adherence; Methotrexate; Pneumonitis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bluett, J. A. (2016). Developing and investigating response markers to methotrexate in rheumatoid arthritis. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/developing-and-investigating-response-markers-to-methotrexate-in-rheumatoid-arthritis(3e6f6c3b-49ca-4502-be64-884e49a69e4b).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.734228

Chicago Manual of Style (16th Edition):

Bluett, James A. “Developing and investigating response markers to methotrexate in rheumatoid arthritis.” 2016. Doctoral Dissertation, University of Manchester. Accessed April 19, 2019. https://www.research.manchester.ac.uk/portal/en/theses/developing-and-investigating-response-markers-to-methotrexate-in-rheumatoid-arthritis(3e6f6c3b-49ca-4502-be64-884e49a69e4b).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.734228.

MLA Handbook (7th Edition):

Bluett, James A. “Developing and investigating response markers to methotrexate in rheumatoid arthritis.” 2016. Web. 19 Apr 2019.

Vancouver:

Bluett JA. Developing and investigating response markers to methotrexate in rheumatoid arthritis. [Internet] [Doctoral dissertation]. University of Manchester; 2016. [cited 2019 Apr 19]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/developing-and-investigating-response-markers-to-methotrexate-in-rheumatoid-arthritis(3e6f6c3b-49ca-4502-be64-884e49a69e4b).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.734228.

Council of Science Editors:

Bluett JA. Developing and investigating response markers to methotrexate in rheumatoid arthritis. [Doctoral Dissertation]. University of Manchester; 2016. Available from: https://www.research.manchester.ac.uk/portal/en/theses/developing-and-investigating-response-markers-to-methotrexate-in-rheumatoid-arthritis(3e6f6c3b-49ca-4502-be64-884e49a69e4b).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.734228


University of Manchester

6. Bluett, James. Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis.

Degree: 2016, University of Manchester

 IntroductionRheumatoid arthritis (RA) is a multisystem disease associated with early mortality. Methotrexate (MTX) is the first-line therapy in RA but is associated with significant adverse… (more)

Subjects/Keywords: Rheumatoid arthritis; Adherence; Methotrexate; Pneumonitis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bluett, J. (2016). Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:296014

Chicago Manual of Style (16th Edition):

Bluett, James. “Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis.” 2016. Doctoral Dissertation, University of Manchester. Accessed April 19, 2019. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:296014.

MLA Handbook (7th Edition):

Bluett, James. “Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis.” 2016. Web. 19 Apr 2019.

Vancouver:

Bluett J. Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis. [Internet] [Doctoral dissertation]. University of Manchester; 2016. [cited 2019 Apr 19]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:296014.

Council of Science Editors:

Bluett J. Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis. [Doctoral Dissertation]. University of Manchester; 2016. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:296014


University of Aberdeen

7. Almalag, Haya. Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis.

Degree: PhD, 2015, University of Aberdeen

 Background: Rheumatoid arthritis (RA) is an inflammatory disease associated with an increased risk of cardiovascular morbidity and mortality. Methotrexate is a widely used RA medication… (more)

Subjects/Keywords: Methotrexate; Cardiovascular system; Hypertension; Rheumatoid arthritis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Almalag, H. (2015). Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis. (Doctoral Dissertation). University of Aberdeen. Retrieved from http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=228050 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675578

Chicago Manual of Style (16th Edition):

Almalag, Haya. “Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis.” 2015. Doctoral Dissertation, University of Aberdeen. Accessed April 19, 2019. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=228050 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675578.

MLA Handbook (7th Edition):

Almalag, Haya. “Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis.” 2015. Web. 19 Apr 2019.

Vancouver:

Almalag H. Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis. [Internet] [Doctoral dissertation]. University of Aberdeen; 2015. [cited 2019 Apr 19]. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=228050 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675578.

Council of Science Editors:

Almalag H. Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis. [Doctoral Dissertation]. University of Aberdeen; 2015. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=228050 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675578

8. Bulgarelli, Adriana. Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose.

Degree: PhD, Análises Clínicas, 2010, University of São Paulo

 O Metotrexato (MTX) é um fármaco utilizado como anti-inflamatório no tratamento da artrite reumatóide (AR). O risco de doença cardiovascular em pacientes com AR é… (more)

Subjects/Keywords: Aterosclerose; Atherosclerosis; LDE; Methotrexate; Metotrexato; Nanopartícula

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bulgarelli, A. (2010). Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/9/9136/tde-24052010-162400/ ;

Chicago Manual of Style (16th Edition):

Bulgarelli, Adriana. “Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose.” 2010. Doctoral Dissertation, University of São Paulo. Accessed April 19, 2019. http://www.teses.usp.br/teses/disponiveis/9/9136/tde-24052010-162400/ ;.

MLA Handbook (7th Edition):

Bulgarelli, Adriana. “Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose.” 2010. Web. 19 Apr 2019.

Vancouver:

Bulgarelli A. Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose. [Internet] [Doctoral dissertation]. University of São Paulo; 2010. [cited 2019 Apr 19]. Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-24052010-162400/ ;.

Council of Science Editors:

Bulgarelli A. Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose. [Doctoral Dissertation]. University of São Paulo; 2010. Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-24052010-162400/ ;


University of Cincinnati

9. Pinchasik, Dawn. Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy.

Degree: MS, Medicine: Clinical and Translational Research, 2013, University of Cincinnati

 BACKGROUND: Osteosarcoma is the most common primary malignancy of bone in children and adults. High-dose Methotrexate (MTX) is an important component of osteosarcoma therapy, but… (more)

Subjects/Keywords: Oncology; Osteosarcoma; methotrexate; osteosarcoma therapy; toxicity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pinchasik, D. (2013). Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy. (Masters Thesis). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870526

Chicago Manual of Style (16th Edition):

Pinchasik, Dawn. “Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy.” 2013. Masters Thesis, University of Cincinnati. Accessed April 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870526.

MLA Handbook (7th Edition):

Pinchasik, Dawn. “Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy.” 2013. Web. 19 Apr 2019.

Vancouver:

Pinchasik D. Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy. [Internet] [Masters thesis]. University of Cincinnati; 2013. [cited 2019 Apr 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870526.

Council of Science Editors:

Pinchasik D. Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy. [Masters Thesis]. University of Cincinnati; 2013. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870526

10. Gouveia, Viviane de Araújo. Impacto do metotrexato na reestenose após implante de stent coronariano convencional .

Degree: 2015, Universidade Federal de Pernambuco

 Introdução: O advento dos stents convencionais e daqueles liberadores de fármacos aboliu o recolhimento elástico provocado pela angioplastia por balão, porém, estes dispositivos apresentaram como… (more)

Subjects/Keywords: Reestenose; Metotrexato; Angioplastia; Restenosis; Methotrexate; Angioplasty

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gouveia, V. d. A. (2015). Impacto do metotrexato na reestenose após implante de stent coronariano convencional . (Thesis). Universidade Federal de Pernambuco. Retrieved from http://repositorio.ufpe.br/handle/123456789/16384

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gouveia, Viviane de Araújo. “Impacto do metotrexato na reestenose após implante de stent coronariano convencional .” 2015. Thesis, Universidade Federal de Pernambuco. Accessed April 19, 2019. http://repositorio.ufpe.br/handle/123456789/16384.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gouveia, Viviane de Araújo. “Impacto do metotrexato na reestenose após implante de stent coronariano convencional .” 2015. Web. 19 Apr 2019.

Vancouver:

Gouveia VdA. Impacto do metotrexato na reestenose após implante de stent coronariano convencional . [Internet] [Thesis]. Universidade Federal de Pernambuco; 2015. [cited 2019 Apr 19]. Available from: http://repositorio.ufpe.br/handle/123456789/16384.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gouveia VdA. Impacto do metotrexato na reestenose após implante de stent coronariano convencional . [Thesis]. Universidade Federal de Pernambuco; 2015. Available from: http://repositorio.ufpe.br/handle/123456789/16384

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Bradford

11. Elbakay, Jamal Ali Mohamed. Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics.

Degree: PhD, 2017, University of Bradford

Methotrexate (MTX) is an antimetabolite anticancer agent that is used in treatment of multiple cancers, such as acute lymphoblastic leukaemia and osteosarcoma. A lack of… (more)

Subjects/Keywords: 616.99; Cancer; Prodrug; Methotrexate; HDMTX; Matrix Metalloproteinase (MMP); Peptide; Anticancer agents; Methotrexate (MTX)

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Elbakay, J. A. M. (2017). Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics. (Doctoral Dissertation). University of Bradford. Retrieved from http://hdl.handle.net/10454/15102

Chicago Manual of Style (16th Edition):

Elbakay, Jamal Ali Mohamed. “Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics.” 2017. Doctoral Dissertation, University of Bradford. Accessed April 19, 2019. http://hdl.handle.net/10454/15102.

MLA Handbook (7th Edition):

Elbakay, Jamal Ali Mohamed. “Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics.” 2017. Web. 19 Apr 2019.

Vancouver:

Elbakay JAM. Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics. [Internet] [Doctoral dissertation]. University of Bradford; 2017. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10454/15102.

Council of Science Editors:

Elbakay JAM. Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics. [Doctoral Dissertation]. University of Bradford; 2017. Available from: http://hdl.handle.net/10454/15102

12. KURATA, Tomohiko. Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性.

Degree: 博士(医学), 2017, Mie University / 三重大学

Purpose: Pemetrexed transport by human organic anion transporters, hOAT1 (SLC22A6) and hOAT3 (SLC22A8), were characterized in comparison with methotrexate. Methods: Accumulation of pemetrexed and methotrexate(more)

Subjects/Keywords: pemetrexed; organic anion transporter; methotrexate; renal tubular secretion; drug interaction

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

KURATA, T. (2017). Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性. (Thesis). Mie University / 三重大学. Retrieved from http://hdl.handle.net/10076/00016982

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

KURATA, Tomohiko. “Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性.” 2017. Thesis, Mie University / 三重大学. Accessed April 19, 2019. http://hdl.handle.net/10076/00016982.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

KURATA, Tomohiko. “Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性.” 2017. Web. 19 Apr 2019.

Vancouver:

KURATA T. Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性. [Internet] [Thesis]. Mie University / 三重大学; 2017. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10076/00016982.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

KURATA T. Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性. [Thesis]. Mie University / 三重大学; 2017. Available from: http://hdl.handle.net/10076/00016982

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

13. Leite Júnior, Antonio Carlos de Arruda. Associação de fármacos antiproliferativos para o tratamento da aterosclerose em coelhos: uso de nanoemulsão lipídica como veículo para etoposídeo e metotrexato.

Degree: Mestrado, Análises Clínicas, 2010, University of São Paulo

Fármacos antiproliferativos vêm sendo utilizados em procedimentos de angioplastia, onde são administrados localmente por meio de \"stentsf̈armacológicos. Embora seja possível que um tratamento sistêmico apresente… (more)

Subjects/Keywords: Aterosclerose; Atherosclerosis; Etoposide; Etoposídeo; Inflamação; Inflammation; Methotrexate; Metotrexato

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Leite Júnior, A. C. d. A. (2010). Associação de fármacos antiproliferativos para o tratamento da aterosclerose em coelhos: uso de nanoemulsão lipídica como veículo para etoposídeo e metotrexato. (Masters Thesis). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/9/9136/tde-11072011-110513/ ;

Chicago Manual of Style (16th Edition):

Leite Júnior, Antonio Carlos de Arruda. “Associação de fármacos antiproliferativos para o tratamento da aterosclerose em coelhos: uso de nanoemulsão lipídica como veículo para etoposídeo e metotrexato.” 2010. Masters Thesis, University of São Paulo. Accessed April 19, 2019. http://www.teses.usp.br/teses/disponiveis/9/9136/tde-11072011-110513/ ;.

MLA Handbook (7th Edition):

Leite Júnior, Antonio Carlos de Arruda. “Associação de fármacos antiproliferativos para o tratamento da aterosclerose em coelhos: uso de nanoemulsão lipídica como veículo para etoposídeo e metotrexato.” 2010. Web. 19 Apr 2019.

Vancouver:

Leite Júnior ACdA. Associação de fármacos antiproliferativos para o tratamento da aterosclerose em coelhos: uso de nanoemulsão lipídica como veículo para etoposídeo e metotrexato. [Internet] [Masters thesis]. University of São Paulo; 2010. [cited 2019 Apr 19]. Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-11072011-110513/ ;.

Council of Science Editors:

Leite Júnior ACdA. Associação de fármacos antiproliferativos para o tratamento da aterosclerose em coelhos: uso de nanoemulsão lipídica como veículo para etoposídeo e metotrexato. [Masters Thesis]. University of São Paulo; 2010. Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-11072011-110513/ ;


Temple University

14. Wang, Zhan. IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE.

Degree: PhD, 2012, Temple University

Pharmaceutical Sciences

This dissertation presents an investigation of the impact of Multidrug Resistance-associated Protein 2/ATP-binding cassette superfamily C member 2 (Mrp2/Abcc2) and 3 (Mrp3/Abcc3) on… (more)

Subjects/Keywords: Pharmaceutical sciences; ABC transporters; Dose-dependent disposition; Methotrexate; Pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, Z. (2012). IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,179025

Chicago Manual of Style (16th Edition):

Wang, Zhan. “IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE.” 2012. Doctoral Dissertation, Temple University. Accessed April 19, 2019. http://digital.library.temple.edu/u?/p245801coll10,179025.

MLA Handbook (7th Edition):

Wang, Zhan. “IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE.” 2012. Web. 19 Apr 2019.

Vancouver:

Wang Z. IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE. [Internet] [Doctoral dissertation]. Temple University; 2012. [cited 2019 Apr 19]. Available from: http://digital.library.temple.edu/u?/p245801coll10,179025.

Council of Science Editors:

Wang Z. IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE. [Doctoral Dissertation]. Temple University; 2012. Available from: http://digital.library.temple.edu/u?/p245801coll10,179025


Temple University

15. GANTI, VAISHNAVI. A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE.

Degree: PhD, 2014, Temple University

Pharmaceutical Sciences

Chemotherapy related neurotoxicity is the decrease in cognitive function observed in patients receiving chemotherapy for breast cancer. For cancers with higher survival rates… (more)

Subjects/Keywords: Pharmaceutical sciences;

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

GANTI, V. (2014). A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,262852

Chicago Manual of Style (16th Edition):

GANTI, VAISHNAVI. “A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE.” 2014. Doctoral Dissertation, Temple University. Accessed April 19, 2019. http://digital.library.temple.edu/u?/p245801coll10,262852.

MLA Handbook (7th Edition):

GANTI, VAISHNAVI. “A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE.” 2014. Web. 19 Apr 2019.

Vancouver:

GANTI V. A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE. [Internet] [Doctoral dissertation]. Temple University; 2014. [cited 2019 Apr 19]. Available from: http://digital.library.temple.edu/u?/p245801coll10,262852.

Council of Science Editors:

GANTI V. A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE. [Doctoral Dissertation]. Temple University; 2014. Available from: http://digital.library.temple.edu/u?/p245801coll10,262852


University of Alberta

16. Burres, Neal S. The mechanism of action of methotrexate-induced BeWo cell differentiation.

Degree: PhD, Department of Biochemistry, 1985, University of Alberta

Subjects/Keywords: Cell differentiation.; Choriocarcinoma.; Methotrexate.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Burres, N. S. (1985). The mechanism of action of methotrexate-induced BeWo cell differentiation. (Doctoral Dissertation). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/5712m888x

Chicago Manual of Style (16th Edition):

Burres, Neal S. “The mechanism of action of methotrexate-induced BeWo cell differentiation.” 1985. Doctoral Dissertation, University of Alberta. Accessed April 19, 2019. https://era.library.ualberta.ca/files/5712m888x.

MLA Handbook (7th Edition):

Burres, Neal S. “The mechanism of action of methotrexate-induced BeWo cell differentiation.” 1985. Web. 19 Apr 2019.

Vancouver:

Burres NS. The mechanism of action of methotrexate-induced BeWo cell differentiation. [Internet] [Doctoral dissertation]. University of Alberta; 1985. [cited 2019 Apr 19]. Available from: https://era.library.ualberta.ca/files/5712m888x.

Council of Science Editors:

Burres NS. The mechanism of action of methotrexate-induced BeWo cell differentiation. [Doctoral Dissertation]. University of Alberta; 1985. Available from: https://era.library.ualberta.ca/files/5712m888x


Univerzitet u Beogradu

17. Vejnović, Dubravka T. Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom.

Degree: Biološki fakultet, 2017, Univerzitet u Beogradu

humana genetika - farmakogenetika / human genetics - pharmacogenetics

Reumatoidni artritis (RA) je hronična autoimuna bolest koju karakteriše hronično zapaljenje, oštećenje zglobova i bol. Najčešće… (more)

Subjects/Keywords: rheumatoid arthritis; methotrexate; gene polymorphisms; efficacy; adverse drug effects

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vejnović, D. T. (2017). Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:15996/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Vejnović, Dubravka T. “Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom.” 2017. Thesis, Univerzitet u Beogradu. Accessed April 19, 2019. https://fedorabg.bg.ac.rs/fedora/get/o:15996/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Vejnović, Dubravka T. “Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom.” 2017. Web. 19 Apr 2019.

Vancouver:

Vejnović DT. Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom. [Internet] [Thesis]. Univerzitet u Beogradu; 2017. [cited 2019 Apr 19]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:15996/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Vejnović DT. Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom. [Thesis]. Univerzitet u Beogradu; 2017. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:15996/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


The Ohio State University

18. Fan, Yongjia. Bistability in Human Dihydrofolate Reductase Catalysis.

Degree: MS, Chemical and Biomolecular Engineering, 2010, The Ohio State University

  Bistability is the existence of two stable steady states consistent with the same operating conditions. The mechanism for bistability is generally presumed to lie… (more)

Subjects/Keywords: Chemical Engineering; Bistability; human dihydrofolate reductase; methotrexate; thymidylate synthesis pathway

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fan, Y. (2010). Bistability in Human Dihydrofolate Reductase Catalysis. (Masters Thesis). The Ohio State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=osu1280243471

Chicago Manual of Style (16th Edition):

Fan, Yongjia. “Bistability in Human Dihydrofolate Reductase Catalysis.” 2010. Masters Thesis, The Ohio State University. Accessed April 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1280243471.

MLA Handbook (7th Edition):

Fan, Yongjia. “Bistability in Human Dihydrofolate Reductase Catalysis.” 2010. Web. 19 Apr 2019.

Vancouver:

Fan Y. Bistability in Human Dihydrofolate Reductase Catalysis. [Internet] [Masters thesis]. The Ohio State University; 2010. [cited 2019 Apr 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1280243471.

Council of Science Editors:

Fan Y. Bistability in Human Dihydrofolate Reductase Catalysis. [Masters Thesis]. The Ohio State University; 2010. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1280243471


University of Otago

19. Korell, Julia. Modelling Red Blood Cell Data .

Degree: 2012, University of Otago

 The overarching aim of this work was to utilise modelling and simulation methodology to obtain a better understanding of clinical data generated from or in… (more)

Subjects/Keywords: lifespan; mathematical model; pharmacometrics; methotrexate; red blood cell; pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Korell, J. (2012). Modelling Red Blood Cell Data . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/2659

Chicago Manual of Style (16th Edition):

Korell, Julia. “Modelling Red Blood Cell Data .” 2012. Doctoral Dissertation, University of Otago. Accessed April 19, 2019. http://hdl.handle.net/10523/2659.

MLA Handbook (7th Edition):

Korell, Julia. “Modelling Red Blood Cell Data .” 2012. Web. 19 Apr 2019.

Vancouver:

Korell J. Modelling Red Blood Cell Data . [Internet] [Doctoral dissertation]. University of Otago; 2012. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10523/2659.

Council of Science Editors:

Korell J. Modelling Red Blood Cell Data . [Doctoral Dissertation]. University of Otago; 2012. Available from: http://hdl.handle.net/10523/2659


University of Otago

20. Pan, Shan. Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis .

Degree: University of Otago

 Rheumatoid arthritis (RA) is a common inflammatory disease that affects between 0.5% and 1% of adults in developed countries. It is a chronic and progressive… (more)

Subjects/Keywords: pharmacometrics; methotrexate; rheumatoid; arthritis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pan, S. (n.d.). Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/6211

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Chicago Manual of Style (16th Edition):

Pan, Shan. “Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis .” Doctoral Dissertation, University of Otago. Accessed April 19, 2019. http://hdl.handle.net/10523/6211.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

MLA Handbook (7th Edition):

Pan, Shan. “Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis .” Web. 19 Apr 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Pan S. Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis . [Internet] [Doctoral dissertation]. University of Otago; [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10523/6211.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Council of Science Editors:

Pan S. Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis . [Doctoral Dissertation]. University of Otago; Available from: http://hdl.handle.net/10523/6211

Note: this citation may be lacking information needed for this citation format:
No year of publication.


University of Aberdeen

21. Prise, Kevin M. Cell death and DNA damage in methotrexate-treated HeLa cells.

Degree: PhD, 1985, University of Aberdeen

 The cancer chemotherapeutic agent methotrexate inhibits the enzyme dihydrofolate reductase leading to a depletion of cellular reduced folates and inhibition of thymidylate synthase. A predicted… (more)

Subjects/Keywords: 572.8; Methotrexate-treated cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Prise, K. M. (1985). Cell death and DNA damage in methotrexate-treated HeLa cells. (Doctoral Dissertation). University of Aberdeen. Retrieved from http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU362655 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378094

Chicago Manual of Style (16th Edition):

Prise, Kevin M. “Cell death and DNA damage in methotrexate-treated HeLa cells.” 1985. Doctoral Dissertation, University of Aberdeen. Accessed April 19, 2019. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU362655 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378094.

MLA Handbook (7th Edition):

Prise, Kevin M. “Cell death and DNA damage in methotrexate-treated HeLa cells.” 1985. Web. 19 Apr 2019.

Vancouver:

Prise KM. Cell death and DNA damage in methotrexate-treated HeLa cells. [Internet] [Doctoral dissertation]. University of Aberdeen; 1985. [cited 2019 Apr 19]. Available from: http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU362655 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378094.

Council of Science Editors:

Prise KM. Cell death and DNA damage in methotrexate-treated HeLa cells. [Doctoral Dissertation]. University of Aberdeen; 1985. Available from: http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU362655 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378094

22. Atal, Sezen. Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi .

Degree: Histoloji ve Embriyoloji, 2014, Eskisehir Osmangazi University

 Metotreksat, kanser tedavisinde sıklıkla kullanılan kemoterapotik bir maddedir. Ayrıca testis üzerinde de toksik bir etki göstermektedir. Hücre ve dokular, meydana gelen bu toksik etkilerden kurkumin… (more)

Subjects/Keywords: Metotreksat; Kurkumin; Sıçan; Testis; Methotrexate; Curcumin; Rat; Testis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Atal, S. (2014). Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi . (Thesis). Eskisehir Osmangazi University. Retrieved from http://hdl.handle.net/11684/294

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Atal, Sezen. “Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi .” 2014. Thesis, Eskisehir Osmangazi University. Accessed April 19, 2019. http://hdl.handle.net/11684/294.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Atal, Sezen. “Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi .” 2014. Web. 19 Apr 2019.

Vancouver:

Atal S. Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi . [Internet] [Thesis]. Eskisehir Osmangazi University; 2014. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/11684/294.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Atal S. Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi . [Thesis]. Eskisehir Osmangazi University; 2014. Available from: http://hdl.handle.net/11684/294

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

23. Bitoun, Samuel. Mise au point de modèles animaux pour étudier la physiopathologie de la polyarthrite rhumatoïde et le rôle du méthotrexate dans la tolérisation : Development of new animal models to study the pathophysiology of RA and the role of methotrexate-induced tolerance.

Degree: Docteur es, Immunologie, 2018, Paris Saclay

La polyarthrite rhumatoïde (PR) est une maladie auto-immune (MAI) dans laquelle des anticorps anti-peptides citrullinés (ACPA) sont un outil diagnostique très spécifique. L’un des traitements… (more)

Subjects/Keywords: Polyarthrite rhumatoide; Citrulline; Méthotrexate; Baff; Rheumatoid arthritis; Citrulline; Methotrexate; Baff

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bitoun, S. (2018). Mise au point de modèles animaux pour étudier la physiopathologie de la polyarthrite rhumatoïde et le rôle du méthotrexate dans la tolérisation : Development of new animal models to study the pathophysiology of RA and the role of methotrexate-induced tolerance. (Doctoral Dissertation). Paris Saclay. Retrieved from http://www.theses.fr/2018SACLS174

Chicago Manual of Style (16th Edition):

Bitoun, Samuel. “Mise au point de modèles animaux pour étudier la physiopathologie de la polyarthrite rhumatoïde et le rôle du méthotrexate dans la tolérisation : Development of new animal models to study the pathophysiology of RA and the role of methotrexate-induced tolerance.” 2018. Doctoral Dissertation, Paris Saclay. Accessed April 19, 2019. http://www.theses.fr/2018SACLS174.

MLA Handbook (7th Edition):

Bitoun, Samuel. “Mise au point de modèles animaux pour étudier la physiopathologie de la polyarthrite rhumatoïde et le rôle du méthotrexate dans la tolérisation : Development of new animal models to study the pathophysiology of RA and the role of methotrexate-induced tolerance.” 2018. Web. 19 Apr 2019.

Vancouver:

Bitoun S. Mise au point de modèles animaux pour étudier la physiopathologie de la polyarthrite rhumatoïde et le rôle du méthotrexate dans la tolérisation : Development of new animal models to study the pathophysiology of RA and the role of methotrexate-induced tolerance. [Internet] [Doctoral dissertation]. Paris Saclay; 2018. [cited 2019 Apr 19]. Available from: http://www.theses.fr/2018SACLS174.

Council of Science Editors:

Bitoun S. Mise au point de modèles animaux pour étudier la physiopathologie de la polyarthrite rhumatoïde et le rôle du méthotrexate dans la tolérisation : Development of new animal models to study the pathophysiology of RA and the role of methotrexate-induced tolerance. [Doctoral Dissertation]. Paris Saclay; 2018. Available from: http://www.theses.fr/2018SACLS174


University of California – San Diego

24. Beck, Sungjun. Mechanism of Action of Methotrexate Against Zika Virus.

Degree: Biology, 2018, University of California – San Diego

 Zika Virus (ZIKV), which is associated with microcephaly and Guillain-Barré syndrome, brought a serious public health impact to most of Latin America countries in 2015… (more)

Subjects/Keywords: Biology; Dihydrofolate reductase; High throughput screening; Methotrexate; Zika virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Beck, S. (2018). Mechanism of Action of Methotrexate Against Zika Virus. (Thesis). University of California – San Diego. Retrieved from http://www.escholarship.org/uc/item/4ch0p661

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Beck, Sungjun. “Mechanism of Action of Methotrexate Against Zika Virus.” 2018. Thesis, University of California – San Diego. Accessed April 19, 2019. http://www.escholarship.org/uc/item/4ch0p661.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Beck, Sungjun. “Mechanism of Action of Methotrexate Against Zika Virus.” 2018. Web. 19 Apr 2019.

Vancouver:

Beck S. Mechanism of Action of Methotrexate Against Zika Virus. [Internet] [Thesis]. University of California – San Diego; 2018. [cited 2019 Apr 19]. Available from: http://www.escholarship.org/uc/item/4ch0p661.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Beck S. Mechanism of Action of Methotrexate Against Zika Virus. [Thesis]. University of California – San Diego; 2018. Available from: http://www.escholarship.org/uc/item/4ch0p661

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Clemson University

25. Green, Benjamin. FOSINOPRIL, A POTENTIAL SUBSTRATE FOR MRP2, COMPETES WITH SEVERAL HIGH USE PHARMACEUTICALS FOR ELIMINATION.

Degree: MS, Biological Sciences, 2010, Clemson University

 The multidrug-resistance associated protein 2 (MRP2) is a membrane-bound transporter responsible for the efflux of a variety of drugs and endogenous compounds. MDCK cells transfected… (more)

Subjects/Keywords: : Multidrug resistance-associated protein 2; fosinopril; methotrexate; Molecular Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Green, B. (2010). FOSINOPRIL, A POTENTIAL SUBSTRATE FOR MRP2, COMPETES WITH SEVERAL HIGH USE PHARMACEUTICALS FOR ELIMINATION. (Masters Thesis). Clemson University. Retrieved from https://tigerprints.clemson.edu/all_theses/893

Chicago Manual of Style (16th Edition):

Green, Benjamin. “FOSINOPRIL, A POTENTIAL SUBSTRATE FOR MRP2, COMPETES WITH SEVERAL HIGH USE PHARMACEUTICALS FOR ELIMINATION.” 2010. Masters Thesis, Clemson University. Accessed April 19, 2019. https://tigerprints.clemson.edu/all_theses/893.

MLA Handbook (7th Edition):

Green, Benjamin. “FOSINOPRIL, A POTENTIAL SUBSTRATE FOR MRP2, COMPETES WITH SEVERAL HIGH USE PHARMACEUTICALS FOR ELIMINATION.” 2010. Web. 19 Apr 2019.

Vancouver:

Green B. FOSINOPRIL, A POTENTIAL SUBSTRATE FOR MRP2, COMPETES WITH SEVERAL HIGH USE PHARMACEUTICALS FOR ELIMINATION. [Internet] [Masters thesis]. Clemson University; 2010. [cited 2019 Apr 19]. Available from: https://tigerprints.clemson.edu/all_theses/893.

Council of Science Editors:

Green B. FOSINOPRIL, A POTENTIAL SUBSTRATE FOR MRP2, COMPETES WITH SEVERAL HIGH USE PHARMACEUTICALS FOR ELIMINATION. [Masters Thesis]. Clemson University; 2010. Available from: https://tigerprints.clemson.edu/all_theses/893


University of Cincinnati

26. Manna, Soumyarwit. Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases.

Degree: PhD, Engineering and Applied Science: Materials Science, 2016, University of Cincinnati

 A drug delivery device (micro-implant) providing sustained release of <i> hydrophilic </i> drugs has the potential to improve the therapeutic outcome for treatment of vitreoretinal… (more)

Subjects/Keywords: Materials Science; Vitreoretinal; Chitosan; Methotrexate; Polylactic acid; Implant; Drug delivery

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Manna, S. (2016). Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1471346005

Chicago Manual of Style (16th Edition):

Manna, Soumyarwit. “Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases.” 2016. Doctoral Dissertation, University of Cincinnati. Accessed April 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1471346005.

MLA Handbook (7th Edition):

Manna, Soumyarwit. “Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases.” 2016. Web. 19 Apr 2019.

Vancouver:

Manna S. Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases. [Internet] [Doctoral dissertation]. University of Cincinnati; 2016. [cited 2019 Apr 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1471346005.

Council of Science Editors:

Manna S. Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases. [Doctoral Dissertation]. University of Cincinnati; 2016. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1471346005


University of Minnesota

27. Gangar, Amit. Self-assembled nanostructures for the cellular delivery of small molecules, oligonucleotides and proteins for the treatment of cancer.

Degree: PhD, Medicinal Chemistry, 2014, University of Minnesota

 We have developed chemically self-assembled nanostructures (CSANs) as a platform to achieve targeted drug delivery. CSANs are composed of dihydrofolate reductase (DHFR) and its inhibitor… (more)

Subjects/Keywords: Antiodies; Dihydrofolate; Methotrexate; Nanoparticles; Targeted delivery; Medicinal chemistry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gangar, A. (2014). Self-assembled nanostructures for the cellular delivery of small molecules, oligonucleotides and proteins for the treatment of cancer. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/171097

Chicago Manual of Style (16th Edition):

Gangar, Amit. “Self-assembled nanostructures for the cellular delivery of small molecules, oligonucleotides and proteins for the treatment of cancer.” 2014. Doctoral Dissertation, University of Minnesota. Accessed April 19, 2019. http://hdl.handle.net/11299/171097.

MLA Handbook (7th Edition):

Gangar, Amit. “Self-assembled nanostructures for the cellular delivery of small molecules, oligonucleotides and proteins for the treatment of cancer.” 2014. Web. 19 Apr 2019.

Vancouver:

Gangar A. Self-assembled nanostructures for the cellular delivery of small molecules, oligonucleotides and proteins for the treatment of cancer. [Internet] [Doctoral dissertation]. University of Minnesota; 2014. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/11299/171097.

Council of Science Editors:

Gangar A. Self-assembled nanostructures for the cellular delivery of small molecules, oligonucleotides and proteins for the treatment of cancer. [Doctoral Dissertation]. University of Minnesota; 2014. Available from: http://hdl.handle.net/11299/171097


University of Adelaide

28. Fan, Chiaming. Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid.

Degree: 2011, University of Adelaide

 During childhood and adolescence, bone continues to lengthen through endochondral ossification, which occurs within the growth plate and the adjacent metaphysis. As the production of… (more)

Subjects/Keywords: methotrexate; chemotherapy; folinic acid; bone growth; growth plate; bone loss

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fan, C. (2011). Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/69314

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fan, Chiaming. “Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid.” 2011. Thesis, University of Adelaide. Accessed April 19, 2019. http://hdl.handle.net/2440/69314.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fan, Chiaming. “Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid.” 2011. Web. 19 Apr 2019.

Vancouver:

Fan C. Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid. [Internet] [Thesis]. University of Adelaide; 2011. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/2440/69314.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fan C. Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid. [Thesis]. University of Adelaide; 2011. Available from: http://hdl.handle.net/2440/69314

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade do Rio Grande do Sul

29. Oliveira, Catiúscia Padilha de. Desenvolvimento de nanocápsulas de núcleo lipídico com funcionalização de superfície versátil com potencial aplicação para o tratamento da artrite reumatoide e do câncer de mama.

Degree: 2014, Universidade do Rio Grande do Sul

 A área das Ciências Farmacêuticas busca constantemente por tratamentos mais eficientes, direcionados para alvos específicos, com diminuição da dose necessária e com a minimização dos… (more)

Subjects/Keywords: Lipid-core nanocapsules; Farmácia; Multiwall lipid-core nanocapsules; Methotrexate; Bromelain; Etanercept; Infliximab; Breast cancer; Arthritis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Oliveira, C. P. d. (2014). Desenvolvimento de nanocápsulas de núcleo lipídico com funcionalização de superfície versátil com potencial aplicação para o tratamento da artrite reumatoide e do câncer de mama. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/149493

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Oliveira, Catiúscia Padilha de. “Desenvolvimento de nanocápsulas de núcleo lipídico com funcionalização de superfície versátil com potencial aplicação para o tratamento da artrite reumatoide e do câncer de mama.” 2014. Thesis, Universidade do Rio Grande do Sul. Accessed April 19, 2019. http://hdl.handle.net/10183/149493.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Oliveira, Catiúscia Padilha de. “Desenvolvimento de nanocápsulas de núcleo lipídico com funcionalização de superfície versátil com potencial aplicação para o tratamento da artrite reumatoide e do câncer de mama.” 2014. Web. 19 Apr 2019.

Vancouver:

Oliveira CPd. Desenvolvimento de nanocápsulas de núcleo lipídico com funcionalização de superfície versátil com potencial aplicação para o tratamento da artrite reumatoide e do câncer de mama. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2014. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10183/149493.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Oliveira CPd. Desenvolvimento de nanocápsulas de núcleo lipídico com funcionalização de superfície versátil com potencial aplicação para o tratamento da artrite reumatoide e do câncer de mama. [Thesis]. Universidade do Rio Grande do Sul; 2014. Available from: http://hdl.handle.net/10183/149493

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

30. Pereira, Natalia Rubio Claret. Eficácia terapêutica de nanocápsulas de metotrexato em glioblastoma murino: estudos in vivo e in vitro.

Degree: Mestrado, Toxicologia e Análises Toxicológicas, 2015, University of São Paulo

O glioblastoma multiforme (GBM) é uma doença grave e sem tratamento eficaz, especialmente pelos agentes terapêuticos disponíveis causarem reações adversas importantes nas doses terapêuticas. O… (more)

Subjects/Keywords: Barreira hematoencefálica; Blood-Brain barrier; Glioblastoma murino; Methotrexate; Metotrexato; Murine glioblastoma; Nanocápsulas; Nanocapsules

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pereira, N. R. C. (2015). Eficácia terapêutica de nanocápsulas de metotrexato em glioblastoma murino: estudos in vivo e in vitro. (Masters Thesis). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/9/9141/tde-02062015-134406/ ;

Chicago Manual of Style (16th Edition):

Pereira, Natalia Rubio Claret. “Eficácia terapêutica de nanocápsulas de metotrexato em glioblastoma murino: estudos in vivo e in vitro.” 2015. Masters Thesis, University of São Paulo. Accessed April 19, 2019. http://www.teses.usp.br/teses/disponiveis/9/9141/tde-02062015-134406/ ;.

MLA Handbook (7th Edition):

Pereira, Natalia Rubio Claret. “Eficácia terapêutica de nanocápsulas de metotrexato em glioblastoma murino: estudos in vivo e in vitro.” 2015. Web. 19 Apr 2019.

Vancouver:

Pereira NRC. Eficácia terapêutica de nanocápsulas de metotrexato em glioblastoma murino: estudos in vivo e in vitro. [Internet] [Masters thesis]. University of São Paulo; 2015. [cited 2019 Apr 19]. Available from: http://www.teses.usp.br/teses/disponiveis/9/9141/tde-02062015-134406/ ;.

Council of Science Editors:

Pereira NRC. Eficácia terapêutica de nanocápsulas de metotrexato em glioblastoma murino: estudos in vivo e in vitro. [Masters Thesis]. University of São Paulo; 2015. Available from: http://www.teses.usp.br/teses/disponiveis/9/9141/tde-02062015-134406/ ;

[1] [2] [3] [4] [5]

.